How Robust Virus Removal Techniques Can Help Prepare For The Unexpected
Perspectives For The Clearance Of Emerging Viruses
Biopharmaceutical manufacturing processes require a holistic virus safety strategy to prevent the transmission of infectious diseases by viruses. Especially manufacturers of plasma-derived medicinal products (PDMPs) face increased challenges in meeting these regulatory requirements as the main raw material is of human origin and may therefore be contaminated with pathogens that can cause direct infections in patients.
In this webinar, Michael Lasse, PhD, Product Manager Virus Clearance, discusses these challenges as well as the points to consider when implementing virus safety concepts. He also presents the benefits of virus filtration when establishing effective and reliable virus clearance steps within PDMP production. In addition, he emphasizes the importance of robust, scalable virus clearance technologies such as Virosart® HC for the removal of emerging viruses like SARS-CoV-2.
Key Learning Objectives:
Gain insight into virus safety strategies and virus clearance concepts
Understand the impact of emerging viruses on established virus safety concepts
Learn about methods and techniques utilized in virus clearance studies for PDMPs
Find out more about the application of virus filtration and Virosart® HC in the production of PDMPs
Meet Our Experts
Michael Lasse, PhD
Product Manager Virus Clearance
Michael Lasse joined Sartorius Stedim Biotech in December 2019 as Product Manager Virus Clearance. He has more than 6 years of experience in the biotechnology and bioprocessing industry. Prior to joining Sartorius, he worked as Study Director for Virus Clearance studies and was a team lead focussing on chromatography and virus safety at Charles River Laboratories in Cologne, Germany. He holds a Diploma in Biology from the University of Rostock, Germany and a PhD in Biochemistry from the University of Cologne, Germany. During his studies he worked on recombinant protein expression in various prokaryotic and eukaryotic systems and protein purification via chromatography.
